MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
Authors:
- Weiqing LiWLWeiqing Li
- Yongji YangYYYongji Yang
- Yicheng LuYLYicheng Lu
- Cheng HeCHCheng He
- Guohan HuGHGuohan Hu
- Huimin LiuHLHuimin Liu
- Juxiang ChenJCJuxiang Chen
- Jin HeJHJin He
- Hongyu YuHYHongyu Yu
- 1 August 2009
- journal article
- Published by Elsevier in Brain Research
- Vol. 1286, 13-18
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- MicroRNA-21 Knockdown Disrupts Glioma Growth In vivo and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human GliomasCancer Research, 2007
- MicroRNA expression profiles for the NCI-60 cancer cell panelMolecular Cancer Therapeutics, 2007
- Multiple paths to a drug resistance phenotype: Mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs☆Drug Resistance Updates, 2007
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma CellsCancer Research, 2005
- Real-time quantification of microRNAs by stem-loop RT-PCRNucleic Acids Research, 2005
- MicroRNAsCell, 2004
- Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cellsBlood, 2001
- Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiformeCancer, 1998
- Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adultsCancer, 1993